Historical record - last NADAC effective date: 9/19/2018
Product Information
MORPHINE SULFATE ER 100 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $12.6512 per EA under NDC 00115128201. Its NADAC has been published 119 times since Feb 8, 2017.
FDA first approved this application on Apr 12, 2016.
Strength
100 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115128201
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/19/2018
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA200411FDA Approved
4/12/2016
On Market Since
4/12/2016
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 100 MG CAP has been published 119 times since Feb 8, 2017, and over the history we have for it it has risen 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.6512 per EA |
|---|---|
| All-time high | $12.6512 (Sep 11, 2019) |
| All-time low | $10.1674 (Feb 8, 2017) |
| Median price | $10.3215 |
| Average price | $11.3200 |
| Largest weekly change | +22.9% (Sep 19, 2018) |
| Weeks tracked | 119 |
| Tracking since | Feb 8, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+24.4%
Last surveyed Sep 11, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MORPHINE SULFATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 100 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $12.6512 per EA (NDC 00115128201), effective Sep 11, 2019.
How has the price of MORPHINE SULFATE ER 100 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 100 MG CAP has risen 24.4%. It has been tracked across 119 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 100 MG CAP?
Since Feb 8, 2017, the NADAC for MORPHINE SULFATE ER 100 MG CAP has ranged from a low of $10.1674 (Feb 8, 2017) to a high of $12.6512 (Sep 11, 2019), with a median of $10.3215 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 100 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE ER 100 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 100 MG CAP?
MORPHINE SULFATE ER 100 MG CAP (NDC 00115128201) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.